ARKG ETF — Holdings & Market Internals
A visuals-first look inside ARK Genomic Revolution ETF (ARKG): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 34-name holdings snapshot.
Historical breadth is computed against the current ARKG membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 27% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 26.7 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
| FRNM | Freenome, Inc. Common stock | 1.03% | -17.98% | 40 |
| GENB | Generate Biomedicines, Inc. Common Stock | 1.01% | -24.51% | 39 |
| BFLY | Butterfly Network, Inc. | 1.68% | -25.88% | 36 |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 1.52% | -29.41% | 35 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 1.74% | -33.52% | 31 |
| SCTX | Scribe Therapeutics Inc. Common Stock | 1.11% | -41.36% | 34 |
Holdings Explorer
Top 30 by weight — sort any column. View all 34 holdings →
| TXG | 10x Genomics, Inc. Class A Common Stock | Industrials | 8.58% | $71.37 | +2.42% | -5.23% | +54.37% | 46 | 100 | $12.2B |
| TEM | Tempus AI, Inc. Class A Common Stock | Technology | 7.88% | $67.10 | +5.96% | -10.67% | +54.37% | 47 | 36 | $13.9B |
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 7.85% | $138.77 | +3.25% | -11.29% | +49.65% | 44 | 100 | $12.5B |
| CRSP | CRISPR Therapeutics AG | Health Care | 5.53% | $49.30 | -1.18% | -10.12% | +3.63% | 40 | 34 | $5.4B |
| ILMN | Illumina Inc | Health Care | 5.01% | $269.50 | -0.05% | +6.16% | +38.63% | 55 | 99 | $41.2B |
| ABSI | Absci Corporation Common Stock | Health Care | 4.98% | $9.19 | -2.19% | -3.87% | +17.62% | 48 | 98 | $1.9B |
| NTRA | Natera, Inc. Common Stock | Health Care | 4.98% | $405.96 | +0.67% | +3.44% | +53.11% | 57 | 98 | $59.1B |
| GH | Guardant Health, Inc. Common Stock | Health Care | 4.93% | $171.24 | +3.63% | -2.86% | +14.76% | 52 | 99 | $23.9B |
| LLY | Eli Lilly & Co. | Health Care | 4.29% | $1278.93 | -2.12% | +10.10% | +6.03% | 62 | 95 | $1.02T |
| CDNA | CareDx, Inc. | Health Care | 3.89% | $69.42 | +0.04% | +25.18% | +86.00% | 64 | 100 | $3.5B |
| VCYT | Veracyte, Inc. | Health Care | 3.59% | $48.02 | +4.12% | +9.78% | -17.05% | 60 | 90 | $3.7B |
| BEAM | Beam Therapeutics Inc. Common Stock | Health Care | 3.49% | $23.80 | -2.16% | +0.71% | -5.49% | 45 | 39 | $2.5B |
| NRIX | Nurix Therapeutics, Inc. Common stock | Health Care | 2.88% | $25.93 | -0.71% | +6.65% | +7.15% | 58 | 98 | $2.4B |
| CMPS | COMPASS Pathways Plc American Depository Shares | Health Care | 2.85% | $11.27 | -3.96% | -17.79% | -0.71% | 40 | 97 | $1.6B |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | Health Care | 2.74% | $3.67 | +3.35% | +1.37% | +22.11% | 48 | 31 | $2.2B |
| SDGR | Schrodinger, Inc. Common Stock | Health Care | 2.55% | $23.97 | +5.27% | -17.85% | +56.58% | 45 | 78 | $2.3B |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Health Care | 2.24% | $24.87 | +4.47% | -8.89% | +12.38% | 48 | 94 | $4.5B |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Health Care | 1.92% | $43.34 | -2.28% | -1.92% | -24.58% | 40 | 31 | $7.2B |
| NTLA | Intellia Therapeutics, Inc | Health Care | 1.80% | $11.13 | +0.45% | -7.58% | +2.00% | 42 | 26 | $1.7B |
| WGS | GeneDx Holdings Corp. Class A Common Stock | Health Care | 1.74% | $61.36 | -14.30% | -33.52% | -5.42% | 31 | 28 | $2.2B |
| BFLY | Butterfly Network, Inc. | Health Care | 1.68% | $6.83 | +1.32% | -25.88% | +1.05% | 36 | 99 | $2.4B |
| ALMR | Alamar Biosciences, Inc. Common Stock | Industrials | 1.67% | $30.71 | +3.16% | -4.54% | +16.91% | 53 | 0 | $2.2B |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Health Care | 1.52% | $9.83 | -8.39% | -29.41% | +73.39% | 35 | 57 | $370M |
| PRME | Prime Medicine, Inc. Common Stock | Health Care | 1.45% | $3.54 | -1.61% | +18.01% | +23.57% | 54 | 33 | $541M |
| PACB | Pacific Biosciences of California, Inc. | Industrials | 1.16% | $2.10 | +2.43% | +50.71% | +55.15% | 55 | 74 | $790M |
| MASS | 908 Devices Inc. Common Stock | Industrials | 1.12% | $11.48 | +1.06% | +6.39% | +54.85% | 50 | 89 | $525M |
| SCTX | Scribe Therapeutics Inc. Common Stock | Health Care | 1.11% | $15.54 | -14.48% | -41.36% | -28.28% | 34 | 0 | $403M |
| FRNM | Freenome, Inc. Common stock | Health Care | 1.03% | $13.32 | -2.29% | -17.98% | +8.13% | 40 | 0 | $1.7B |
| GENB | Generate Biomedicines, Inc. Common Stock | Health Care | 1.01% | $12.38 | -3.01% | -24.51% | -9.02% | 39 | 0 | $1.8B |
| IAM | Iambic Therapeutics, Inc. Common Stock | Health Care | 0.96% | $14.30 | -3.82% | -- | -- | -- | 0 | $1.1B |